Navigation Links
Trial Shows Heart Attack Education Makes Little Difference
Date:10/7/2009

But new study design might change response times, researcher says

WEDNESDAY, Oct. 7 (HealthDay News) -- A study to tell whether educating heart patients about the symptoms of heart attack would make them respond faster when one happens has produced negative results, but the researchers say a few changes in trial design might make a second look at the issue worthwhile.

The research included 3,522 people with known heart disease in six cities in the United States, Australia and New Zealand. Half were given lessons on the symptoms of a heart attack and what to do when they occurred -- essentially, get to a hospital quickly -- with a follow-up call a month later to be sure the lessons had been learned. The other half received standard medical care. Both groups were called every six months to check whether they had sought emergency heart care.

Among the 3,087 people who were followed for two years, 305 in the education group sought emergency care, compared to 260 in the no-education group. The average time from symptoms to hospital admission was virtually the same for the two groups -- 2.20 hours with education, 2.25 hours without education, the researchers found.

But there should have been a third group in the study, said Barbara J. Riegel, a professor of nursing at the University of Pennsylvania and a member of the consortium of nurses reporting the trial in the Oct. 6 online edition of Circulation.

That would be a group that received neither education nor follow-up phone calls, she said.

The follow-up phone calls made to people in the no-education group might have made them more aware of the need to seek emergency care, Riegel explained.

"The response times were actually pretty low," Riegel said of both groups. "The fact that we called frequently to collect data might have affected their responses."

And so another trial with a third group that is left alone entirely is n
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Vital Therapies Initiates Liver Stabilization Trial
2. Cardiac stem cell trial seeks to treat some heart attack patients
3. UCSF Announces Expanded BreastCancerTrials.org Website
4. 2009 National Ergonomics Conference Coming To Las Vegas In November; Features Strategies For Dealing With A Slow Economy & Aging Workforce In Office, Industrial, Healthcare & Uncontrolled Work Environments
5. Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients
6. Innovation and Global Clinical Trial Participation are the Focus of CenterWatch's Latest Special Report on China's Drug Development Industry
7. Women With Atrial Fibrillation Face Rougher Road Than Men
8. Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
9. Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcanos VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
10. Video: New Clinical Trial Results Show Germ-Killing Action of LISTERINE(R) Antiseptic Kills Germs in the Mouth Before They Travel to the Bloodstream
11. SPIRIT IV trial shows everolimus stent sets new standard for event-free survival

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Low-income children who don,t access health care...m are significantly more likely to have unmet heal... a new study published in the journal Pediatrics ...the financing and delivery of quality health care ... current policy debates about health insurance ref...
(Date:11/23/2009)...bled number of patients who reined in their hypert...3 (HealthDay News) -- High blood pressure is bette...nd-in-hand than by doctors and pharmacists working...ork with pharmacists, medications are intensified,...ely," said Barry L. Carter, a professor in the Uni...
(Date:11/23/2009)...shipswithMinorityBanksin Washington D.C. , N...lumbia , S.C. IntendedtoSpurEconomicGrowthandRe...SNewswire/--DaVita,thenation,sleadingproviderofdia...kInitiativedesignedtocreatejobsandspurrevitalizati...entsinleadingcommunityandminority-ownedbanks.DaVit...
(Date:11/23/2009)...riz.,Nov.23/PRNewswire/--CortivaInstituteTucsonwil...y,Dec.6from1-3p.m.attheschool,s6390EastBroadwayBlv...pantstolearnandpracticebasicmassagestrokes. ,, ...ucsonisgrowingrightalongwithit,"saidJoannMcMaster,...eU.S.DepartmentofLabor,s2009-2010OccupationalOutlo...
(Date:11/23/2009)...ps can impair breathing, protein may be the cause ... U.S. researchers say they,ve identified a protei... to 30 percent of people with chronic sinusitis. ...s of sinusitis, a constant irritation and swelling...wths of sinus tissue -- can block the sinus passag...
Breaking Medicine News(10 mins):Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2Health News:Research Yields Clues to Severe Form of Sinusitis 2
... and corner of its vast territory through satellit...ervices to people, especially those living in far-... the operation of EDUSAT is being expanded across ...irector of the public relations department of ISRO...
...C., by the end of 2007 will begin recording HIV ca...n code-based // reporting systems, the AP/Springfi...g this fiscal year, the funding formulas used by H... Vermont, Maryland and Hawaii are the only st...
...e electronic circuitry using textile's threads to ...e specially designed clothes. // This may sou...y exists in the market. In 1996, researchers... and breathing. Other researchers added tin...
...ely on patients' family members rather than interp...o a study by Johns Hopkins School of Medicine, the... lead author Dennis Kuo, a general pediatrics fell...ans use bilingual staff members and 40% use profes...
...tary has tendered an apology to thousands of junio...ng on a BBC program, Hewitt acknowledged that the ...d that it was “nowhere near where it should have b...ed that has happened. We are now sorting it out.” ...
...n a general feeling of malaise, say researchers.... to even, a stroke. // What stood out most fro...Pariante of the Institute of Psychiatry at King's ...ed ,was that this included even depression of a le...
Other Medicine News:Health News:Satellites Set to Play Good Samaritans in India 2Health News:Satellites Set to Play Good Samaritans in India 3Health News:All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007 2Health News:Health Secretary Apologizes For Failed Online Recruitment System 2Health News:Being Sad Can Kill You 2
(Date:11/23/2009)...LE,Pa.,Nov.23/PRNewswire-FirstCall/--WestPharmaceu...ecompany,sChiefOperatingOfficerMatthewT.Mullarkeyh...andformerChiefOperatingOfficerStevenA.Ellers,58,wi...toprovidemanagerialcontinuityandsupportfollowingMr...tisaglobalmanufacturerofcomponentsandsystemsforinj...
(Date:11/23/2009)...NO,Calif.,Nov.23/PRNewswire-FirstCall/--DURECTCorp...ChiefFinancialOfficer,andJoeStauffer,ChiefMedicalO...HealthCareConferenceonTuesday,December1at3:30pmEas...eHotelinNewYorkCity. ,, (Logo: http://www.newsc...cessthelivepresentationviatheinternet,pleasegototh...
(Date:11/23/2009)...DOAKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amgen(N...ingforBestOverallPipelineandforBestNewDrugforNplat..., TheBestOverallPipelineawardwaspresentedtoAmgen...rketpotentialofthecompany,spipeline,aswellasitsmix...judges,Amgen,spipelineisnotableforitsfocusonunmetc...
Breaking Medicine Technology:DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 1PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 2PEER 1 UK Signs 100 Business Hosting Customers in Three Months 60810 3ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 1ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 2ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 3One Catholic Priest and Eleven Other Pro Lifers Arrested for Tearing Up Nancy Pelosis Health Care Bill Outside Her Office 3B See Video Below 60806 1
...eading Attribute in Antibiotic Selection, Accordin..., , MALVERN, Pa. and WALTHAM, Mass. , May 27 Ar...rces find that surveyed physicians will increase p...Johnson & Johnson,s Doribax in the next five y...ns because of their potent broad-spectrum activity...
...red in Dual Cord Blood Transplant for Hematologic ...herapeutics, Inc. announced today that the first...rial of FT1050, a small molecule Stem Cell Modulat...ell (HSC) number and function through its activati...y, which is being conducted at the Dana-Farber Can...
Other Medicine Technology:Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections 2Carbapenems and Other Agents that Provide Broad-Spectrum Activity are Preferred by Surveyed Physicians for the Treatment of Intra-Abdominal Infections 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 2Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 3Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: